← Back to Search

Corticosteroid

Dexycu for Cataract

Phase 4
Waitlist Available
Led By Robert J Weinstock, MD
Research Sponsored by The Eye Institute of West Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Patients age 40 to 90 years old, with visually significant cataract that received bilateral cataract surgery using either the manual technique or femtosecond assisted cataract surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post operative day 30
Awards & highlights

Study Summary

This study is evaluating whether a new combination of drugs may help reduce inflammation and pain following cataract surgery.

Eligible Conditions
  • Cataract

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post operative day 30
This trial's timeline: 3 weeks for screening, Varies for treatment, and post operative day 30 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inflammation Score
Pain

Trial Design

2Treatment groups
Active Control
Group I: DexycuActive Control1 Intervention
Group II: Standard Care Post operative dropsActive Control1 Intervention

Find a Location

Who is running the clinical trial?

EyePoint Pharmaceuticals, Inc.Industry Sponsor
16 Previous Clinical Trials
1,881 Total Patients Enrolled
4 Trials studying Cataract
737 Patients Enrolled for Cataract
The Eye Institute of West FloridaLead Sponsor
Robert J Weinstock, MDPrincipal InvestigatorThe Eye Institute of West Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
"A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"
2020. ""A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation"". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04781335.
All > Cataract
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top